By VC News Daily
NEW YORK, NY, Gameto, a biotechnology company dedicated to advancing treatment options in women’s health, has closed an oversubscribed $33 million Series B financing round.
Gameto, a biotechnology company dedicated to advancing treatment options in women’s health, has closed an oversubscribed $33 million Series B financing round, led by Two Sigma Ventures with RA Capital and participation from existing investors, including Insight Partners, Future Ventures, and BOLD Capital Partners. Gameto’s investor group is also joined by Olivia Walton’s Ingeborg Investments, Stacey Bendet Eisner, Founder, CEO, and Creative Director of alice + olivia, and Chelsea Hirschhorn, Founder and CEO of Frida.
(c) by Massinvestor, Inc. For contact info, please check out our about page.